课题基金 / 基金详情

Identification of novel genetic modifiers in ß-thalassemia

Identification of novel genetic modifiers in ß-thalassemia
β地中海贫血新型遗传修饰因子的鉴定
批准号:
5411951
负责人:
Professor Dr. Andreas Eckhard Kulozik, Ph.D.
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2004
资助国家:
德国
项目状态:
已结题
起止时间:
2003-12-31 至 2009-12-31

项目摘要

项目成果

Professor Dr. Andreas Eckhard Kulozik, Ph.D.的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The understanding of the phenotypic variability of genetically homogenous disorders represents a major challenge. In b-thalassemia the b-globin gene is affected by a variety of mutations. The group of patients to be analyzed here is homozygous for a splice site mutation that is common in the Middle East. In contrast to this genetic homogeneity the spectrum of the clinical phenotype ranges from mild anemia to most severe, transfusion-depent anemia. We aim at an understanding of this perplexing clinical variability by using a genetic linkage approach to identify modifying factors and by analyzing the effeciency of an mRNA surveillance mechanism that is referred to as nonsense-mediated decay and represents a candidate genetic modifier of b-thalassemia and other genetic disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A global perspective of Exon Junction Complexes in Nonsense-mediated mRNA Decay (NMD)
Clinical variability of beta-thalassemia: quality control of gene expression by nonsense mediated decay
Molecular mechanisms of hereditary thrombophilia: physiological function of prothrombin mRNA 3` end maturation
Analysis of the RNA-interactome governing oncogenesis of osteosarcoma
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: